Exposure-Response Analysis of Venetoclax in Combination with Hypomethylating Agents or Low-Dose Cytarabine in Elderly Patients with Newly Diagnosed Acute Myeloid Leukemia

被引：0
|
作者：
Agarwal, Suresh [1 ]
Gopalakrishnan, Sathej [1 ]
Mensing, Sven [1 ]
Potluri, Jalaja [1 ]
Hayslip, John [1 ]
Friedel, Anna [1 ]
Menon, Rajeev [1 ]
Salem, Ahmed Hamed [1 ]
机构：
[1] AbbVie Inc, N Chicago, IL USA
来源：
BLOOD | 2018年 / 132卷
关键词：
D O I：
10.1182/blood-2018-99-116790
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
5239
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Venetoclax combined with hypomethylating agents or low-dose cytarabine as induction chemotherapy for patients with untreated acute myeloid leukemia ineligible for intensive chemotherapy: a systematic review and meta-analysis
    Qin, Yao
    Kuang, Pu
    Liu, Ting
    CLINICAL AND EXPERIMENTAL MEDICINE, 2023, 23 (02) : 219 - 227
  • [32] Hypomethylating Agents and Low-Dose Venetoclax for Relapse Acute Myeloid Leukemia after Allogeneic Stem Cell Transplantation
    Vigil, Carlos Enrique
    Silverman, Margarida
    Carter, Thomas
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2020, 26 (03) : S104 - S104
  • [33] Cardiac Events in Patients with Acute Myeloid Leukemia Treated with Venetoclax in Combination with Hypomethylating Agents
    Johnson, Isla M.
    Bezerra, Evandro D.
    Farrukh, Faiqa
    McCullough, Kristen
    Al-Kali, Aref
    Alkhateeb, Hassan B.
    Begna, Kebede H.
    Litzow, Mark R.
    Hogan, William J.
    Shah, Mithun V.
    Patnaik, Mrinal M.
    Tefferi, Ayalew
    Gangat, Naseema
    BLOOD, 2021, 138
  • [34] Combination Treatment of Venetoclax and Hypomethylating Agents (HMA) or Low-Dose Cytarabine (LDAC) for Patients with Acute Myeloid Leukemia (AML) - Real-World Data from Two German Academic Centers
    Schmalbrock, Laura K.
    Braitsch, Krischan
    Jung, Paul
    Bumeder, Irmgard
    Kiewe, Philipp
    Westermann, Joerg
    Bullinger, Lars
    Keller, Ulrich
    Bassermann, Florian
    Kroenke, Jan
    Rieger, Kathrin
    Goetze, Katharina S.
    BLOOD, 2021, 138
  • [35] Correlative Biomarkers of Response to Venetoclax (VEN) in Combination with Chemotherapy or Hypomethylating Agents (Hma) in Elderly Untreated Patients with Acute Myeloid Leukemia (AML)
    Chyla, B.
    Popovic, R.
    Potluri, J.
    Hayslip, J.
    Huang, X.
    Mabry, M.
    Bhathena, A.
    ANNALS OF HEMATOLOGY, 2017, 96 : S84 - S85
  • [36] Venetoclax and hypomethylating agent combination therapy in newly diagnosed acute myeloid leukemia: Genotype signatures for response and survival among 301 consecutive patients
    Gangat, Naseema
    Karrar, Omer
    Iftikhar, Moazah
    Mccullough, Kristen
    Johnson, Isla M.
    Abdelmagid, Maymona
    Abdallah, Mostafa
    Al-Kali, Aref
    Alkhateeb, Hassan B.
    Begna, Kebede H.
    Mangaonkar, Abhishek
    Saliba, Antoine N.
    Torghabeh, Mehrdad Hefazi
    Litzow, Mark R.
    Hogan, William
    Shah, Mithun
    Patnaik, Mrinal M.
    Pardanani, Animesh
    Badar, Talha
    Murthy, Hemant
    Foran, James
    Palmer, Jeanne
    Sproat, Lisa
    Khera, Nandita
    Yi, Cecilia Arana
    Tefferi, Ayalew
    AMERICAN JOURNAL OF HEMATOLOGY, 2024, 99 (02) : 193 - 202
  • [37] Response rates in acute myeloid leukemia patients treated with attenuated durations of venetoclax in combination with hypomethylating agents.
    Blanding, Dena
    Jonathan, Bakos Keegan
    Rangel, Christopher Andrew
    Pasyar, Sarah
    Hill, Elizabeth Goodwin
    Davis, James
    Hess, Brian T.
    Baratam, Praneeth
    Greenwell, Irl Brian
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [38] Venetoclax in Combination With Hypomethylating Agents or Low-Dose Cytarabine for Relapsed/Refractory NPM1-Mutated Acute Myeloid Leukemia: Clinical Experience From a Real-Life Setting
    Piccini, Matteo
    Gianfaldoni, Giacomo
    Mannelli, Francesco
    Scappini, Barbara
    Ciolli, Gaia
    Pasquini, Andrea
    Fasano, Laura
    Pilerci, Sofia
    Quinti, Elisa
    Crupi, Francesca
    Guglielmelli, Paola
    Vannucchi, Alessandro Maria
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2023, 23 : S285 - S286
  • [39] A Successful Bridge Therapy Combining Hypomethylating Agents with Venetoclax for Adult Patients with Newly Diagnosed or Relapsed/Refractory Acute Myeloid Leukemia
    Bang, Su-Yeon
    Park, Silvia
    Kwag, Daehun
    Lee, Jong Hyuk
    Min, Gi-June
    Park, Sung-Soo
    Yoon, Jae-Ho
    Lee, Sung-Eun
    Cho, Byung-Sik
    Eom, Ki-Seong
    Kim, Yoo-Jin
    Lee, Seok
    Min, Chang-Ki
    Cho, Seok-Goo
    Lee, Jong Wook
    Kim, Hee-Je
    CANCERS, 2023, 15 (06)
  • [40] Association between Body Mass Index and Outcomes in Patients with Newly Diagnosed Acute Myeloid Leukemia Treated with Hypomethylating Agents and Venetoclax
    Weiss, Julian J.
    Yates, Samuel J.
    Badar, Talha
    Patel, Anand Ashwin
    Winer, Eric S.
    Litzow, Mark R.
    Cheng, Wei
    Lin, Chenyu
    Shallis, Rory M.
    BLOOD, 2024, 144 : 1489 - 1490
12345